Sitagliptin in Type I Diabetic Patients

Summary

The purpose of the study is to evaluate the effect of sitagliptin on overall blood glucose concentrations in Type I Diabetic subjects. The study also aims to evaluate post meal glucagon concentrations in Type I Diabetic subjects (a possible mechanism of reduced blood glucose concentrations) and indices of oxidation stress in the plasma of these subjects.

Timeline

Start

2011-06

Primary completion

2013-09

Completion

2013-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study funding was for 1 year to a fellow who graduated in early stages of enrollment. While 6 patients were enrolled, many patients didn't finish the study and therefore little data was collected and no results will be entered.”

Drugs

Indications